Gadoversetamide
From Wikipedia, the free encyclopedia
Gadoversetamide
|
|
Systematic (IUPAC) name | |
? | |
Identifiers | |
CAS number | |
ATC code | V08 |
PubChem | |
DrugBank | |
Chemical data | |
Formula | C20H34GdN5O10 |
Mol. mass | 661.77 g/mol |
SMILES | & |
Pharmacokinetic data | |
Bioavailability | ? |
Protein binding | Nil |
Metabolism | Nil |
Half life | 80 to 120 minutes |
Excretion | Renal |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status | |
Routes | Intravenous |
Gadoversetamide is a gadolinium compound used as a contrast agent in magnetic resonance imaging (MRI), particularly imaging of the brain, spine and liver.[1] It is marketed under the trade name OptiMARK.
[edit] Notes
- ^ Gadoversetamide Drug Information. Drugs.com (March 20, 2000). Retrieved on 2007-03-23.